CFM
VCYT icon

Catalyst Funds Management’s Veracyte VCYT Stock Holding History

Catalyst Funds Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
9,650
+950
+11% +$39.8K 0.03% 371
2026
Q1 		$280K Buy
8,700
+3,200
+58% +$118K 0.05% 372
2025
Q4 		$232K Sell
5,500
-1,100
-17% -$44.3K 0.05% 268
2025
Q3 		$227K Sell
6,600
-5,700
-46% -$164K 0.03% 395
2025
Q2 		$332K Buy
+12,300
New +$356K 0.09% 257
2024
Q3 		– Sell
-2,000
Closed -$43.3K – 1617
2024
Q2 		$43.3K Buy
2,000
+1,300
+186% +$27.3K 0.01% 461
2024
Q1 		$15.5K Buy
+700
New +$17.1K ﹤0.01% 816

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Catalyst Funds Management's VCYT Position: Q2 2026 in Review

Catalyst Funds Management increased its Veracyte (VCYT) stake by 11% in Q2 2026, buying an estimated $39.8K and bringing the position to 9,650 shares worth $567K. The position accounts for 0.03% of the portfolio, ranked #371.

Catalyst Funds Management first reported a position in VCYT in Q1 2024 and has held it in 7 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Catalyst Funds Management held 9,650 shares of Veracyte worth $567K as of Q2 2026.
  • Catalyst Funds Management bought 950 Veracyte shares in Q2 2026, an estimated $39.8K.
  • Veracyte made up 0.03% of Catalyst Funds Management's portfolio in Q2 2026, its #371 holding.
  • Catalyst Funds Management first reported a position in Veracyte in Q1 2024 and has held it in 7 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.